Decay-accelerating factor (DAF) functions intrinsically in the plasma membranes of host cells to prevent autologous complement activation on their surfaces. The protein comprised of four -61 amino acid long short consensus repeats (SCRs) linked through a membrane proximal stock to a glycoinositol phospholipid (GPI) membrane anchor is freely mobile on cell surfaces and acts by destabilizing the amplification convertases of the cascade wherever autologous deposited C4b or C3b elicit their assembly. DAF's activity is essential physiologically as its deficient expression in paroxysmal nocturnal hemoglobinuria (PNH) underlies the heightened uptake of autologous C3b fragments that characterizes affected cells and contributes to disease pathogenesis. Considerable data have shown that DAF's activity is also important in a wide range of other clinical settings including neoplasms where it can inhibit immune attack and infectious and inflammatory states where augmented expression levels are needed to protect effector cells and nearby tissues from local inflammation. In previous work, we 1) isolated the DAF promoter region and mapped the locations of enhancer and response elements within it, 2) developed methods for producing large quantities of recombinant GPI-anchored variant DAF and other C4b/C3b regulatory proteins and for sensitively analyzing their functional properties, 3) demonstrated that the DAF deficit in PNH cells resides in defective GPI anchor biosynthesis and showed that PNH cells harbor a common defect in assembly of N-acetyl-D- glucosamine (G1cNAc)-inositol phospholipid, the first intermediate of the intracellular GPI anchor synthetic sequence, 4) analyzed subsequent intermediates of the GPI anchor synthetic pathway and prepared human K562 cell mutants with defined lesions in a number of different steps, and 5) characterized PNH marrow and formally demonstrated that affected DAF and unaffected DAF populations of CD34+, CD38 self-renewing progenitors are present. The experiments proposed in this application are directed at 1) characterization of cis sequence elements and transacting nuclear factors that participate in regulation of DAF gene transcription, 2) identification of the structural domains within the DAF molecule which mediate its critical regulatory activity on complement as well as its newly defined activity on certain types of cell-mediated cytotoxicity, 3) analysis of the genetic alteration(s) responsible for defective synthesis of G1cNAc-inositol phospholipid in different PNH patients, 4) isolation and characterization of the genes encoding other enzymes in the GPI anchor biosynthetic pathway, and 5) development of protocols for selectively depleting PNH patients of affected progenitors and returning their unaffected self-renewing CD34+, CD38 stem cells to them via autologous marrow transplants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023598-13
Application #
2653798
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1985-09-30
Project End
2000-01-31
Budget Start
1998-02-01
Budget End
2000-01-31
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Strainic, Michael G; Shevach, Ethan M; An, Fengqi et al. (2013) Absence of signaling into CD4? cells via C3aR and C5aR enables autoinductive TGF-?1 signaling and induction of Foxp3? regulatory T cells. Nat Immunol 14:162-71
Kwan, Wing-Hong; Hashimoto, Daigo; Paz-Artal, Estela et al. (2012) Antigen-presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest 122:2234-8
Plevka, Pavel; Hafenstein, Susan; Harris, Katherine G et al. (2010) Interaction of decay-accelerating factor with echovirus 7. J Virol 84:12665-74
Sakuma, Masashi; Morooka, Toshifumi; Wang, Yunmei et al. (2010) The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury. Arterioscler Thromb Vasc Biol 30:1196-202
Roychowdhury, Sanjoy; McMullen, Megan R; Pritchard, Michele T et al. (2009) An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49:1326-34
Raedler, H; Yang, M; Lalli, P N et al. (2009) Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am J Transplant 9:1784-95
Liu, Jinbo; Lin, Feng; Strainic, Michael G et al. (2008) IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 180:5882-9
Lalli, Peter N; Strainic, Michael G; Yang, Min et al. (2008) Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 112:1759-66
Pavlov, Vasile; Raedler, Hugo; Yuan, Shuguang et al. (2008) Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol 181:4580-9
Strainic, Michael G; Liu, Jinbo; Huang, Danping et al. (2008) Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28:425-35

Showing the most recent 10 out of 68 publications